FDA concerned about some STD medications

The U.S. Food and Drug Administration has warned six companies to stop marketing unapproved drugs for treating and preventing sexually transmitted diseases.

The FDA said some of the products falsely claim to have received FDA approval, while some claim to be more effective than conventional medicine. The products are sold as Tetrasil, Genisil, Aviralex, OXi-MED, Imulux, Beta-mannan, Micronutrient, Qina, and SlicPlus.

Officials said the products claim to prevent or treat a variety of STDs, including herpes, chlamydia, human papilloma virus, cervical dysplasia, and HIV/AIDS. The FDA said it considers the products to be unapproved new drugs marketed in violation of the Federal Food, Drug and Cosmetic Act. Officials said the drugs are also misbranded since they lack proper directions for use by consumers and/or make false and misleading claims.

The FDA identified the companies as Aviralex International of San Francisco; Aidance Skincare & Topical Solutions LLC. of Harmony, R.I.; health-science-report.com; NeumaLife of Boys Town, Neb.; IMULUX LLC. of Fort Smith, Ark.; the Saferex Laboratories International Corp. of Sachse, Texas; and Waldon Research of Christchurch, New Zealand.

Copyright 2008 by United Press International

Related stories:

US Pharmacopeia announces revised heparin monographs and reference standards
Standards updated in response to public health threat associated with blood-thinning drug's adulteration with over-sulfated chondroitin
The U.S. Pharmacopeial (USP) Convention announces that revised monographs for heparin sodium and heparin calcium in the United States Pharmacopeia (USP) are now available and official on the USP Web site. The revised monographs are accompanied by two new and two updated official USP Reference Standards. These public standards allow any party—and particularly the Food and Drug Administration (FDA) and manufacturers—to test heparin sodium and calcium drug substances to assure their quality. All drug manufacturers who market heparin in the United States are required to meet these newly revised standards. The heparin monographs were updated in the interest of public health following the deaths of more than 200 people earlier this year. These deaths are suspected to have resulted from the adulteration of the blood thinner with over-sulfated chondroitin, which is derived from the chemical chondroitin and used in dietary supplements.
Heart defibrillator company signs decree
The U.S. Food and Drug Administration said Medtronic Inc. has agreed to comply with FDA rules in manufacturing its external heart defibrillators.
FDA finishes 'Total Body' products study
The U.S. Food and Drug Administration say its testing of Total Body Formula and Total Body Mega Formula has detected hazardous amounts of chromium.
FDA OKs Relistor for opioid patients
The U.S. Food and Drug Administration has approved Relistor (methylnaltrexone bromide) to help restore bowel function in patients receiving opioids.
Private Selection-brand ice cream recalled
The U.S. Food and Drug Administration announced the recall of Private Selection-brand light churned mint chocolate chip ice cream due to a labeling error.
Herbal Science-brand supplements recalled
The U.S. Food and Drug Administration announced the recall of 12 Herbal Science-brand dietary supplements because they might present a health hazard.
Salmonella causes illnesses in 14 states
The U.S. Food and Drug Administration said at least 23 people in 14 states were diagnosed with salmonella poisoning caused by the same contaminated cereals.
FDA seizes sexual enhancement products
The U.S. Food and Drug Administration announced the seizure by U.S. marshals of more than 14,000 units of Shangai- and Naturale-brand diet supplements.

News discussion:

Medicine & Health news